Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'H-2-receptor antagonist' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 142 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. van Leerdam, ME; Rauws, EAJ
      The role of acid suppressants in upper gastrointestinal ulcer bleeding

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    2. Gillen, D; McColl, KEL
      Problems related to acid rebound and tachyphylaxis

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    3. Hsu, CC; Chen, JJ; Hu, TH; Lu, SN; Changchien, CS
      Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    4. Mimaki, H; Kawauchi, S; Kagawa, S; Ueki, S; Takeuchi, K
      Bicarbonate stimulatory action of nizatidine, a histamine H-2-receptor antagonist, in rat duodenums

      JOURNAL OF PHYSIOLOGY-PARIS
    5. See, MC; Birnbaum, AH; Schechter, CB; Goldenberg, MM; Benkov, KJ
      Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia - Global and quantitative assessment

      DIGESTIVE DISEASES AND SCIENCES
    6. Tsuji, S; Kawano, S; Tsujii, M; Kawai, N; Gunawan, ES; Sun, WH; Hori, M
      Effects of osutidine (T-593) and its enantiomers on gastric mucosal hemodynamics and mucosal integrity in anesthetized rats

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    7. Cohen, JS
      Dose discrepancies between the Physicians' Desk Reference and the medical literature, and their possible role in the high incidence of dose-related adverse drug events

      ARCHIVES OF INTERNAL MEDICINE
    8. Hawkey, CJ
      Management of gastroduodenal ulcers caused by non-steroidal anti-inflammatory drugs

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    9. Arroyo, MT; Lanas, A; Sainz, R
      Prevention and healing of experimental indomethacin-induced gastric lesions: effects of ebrotidine, omeprazole and ranitidine

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    10. Kaneko, E; Hoshihara, Y; Sakaki, N; Harasawa, S; Ashida, K; Asaka, M; Asaki, S; Nakamura, T; Kobayashi, K; Kajiyama, G; Ogawa, N; Yao, T; Muto, Y; Nakazawa, S; Takemoto, T
      Peptic ulcer recurrence during maintenance therapy with H-2-receptor antagonist following first-line therapy with proton pump inhibitor

      JOURNAL OF GASTROENTEROLOGY
    11. Gong, HB; Rashid, M; Nakamura, T; Hattori, K; Nakazawa, M; Kihara, H; Yoshimoto, R; Nagatomo, T
      Inhibitory effects of a newly synthesized 5-HT2 receptor antagonist, AT-1015 (N-[2-[4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidino]-ethyl]-1-formyl-4-piperidinecarboxamide monohydrochloride monohydrate), on contraction and relaxation of pig coronary arteries induced by 5-HT and alpha-methylserotonin: Comparison with ketanserin

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    12. Vandenplas, Y; Hegar, B
      Diagnosis and treatment of gastro-oesophageal reflux disease in infants and children

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    13. Otsuka, W; Fukushima, Y; Tamai, M; Takahashi, H; Mori, H; Asano, T; Katsube, T; Ogawa, K; Kajiwara, T; Ohkawa, SI; Saitoh, T
      Long-lasting binding of IT-066 to human histamine H-2 receptor

      DIGESTIVE DISEASES AND SCIENCES
    14. Morisset, M; Moneret-Vautrin, DA; Loppinet, V; Grandidier, S
      Cross-allergy to ranitidine and nizatidine

      ALLERGY
    15. Okajima, K; Murakami, K; Liu, WG; Uchiba, M
      Inhibition of neutrophil activation by ranitidine contributes to prevent stress-induced gastric mucosal injury in rats

      CRITICAL CARE MEDICINE
    16. Scaccianoce, S; Lombardo, K; Nicolai, R; Affricano, D; Angelucci, L
      Studies on the involvement of histamine in the hypothalamic-pituitary-adrenal axis activation induced by nerve growth factor

      LIFE SCIENCES
    17. Sentellas, S; Puignou, L; Moyano, E; Galceran, MT
      Determination of ebrotidine and its metabolites by capillary electrophoresis with UV and mass spectrometry detection

      JOURNAL OF CHROMATOGRAPHY A
    18. Kimura, K; Adachi, M; Kubo, K
      H-1- and H-2-receptor antagonists prevent histamine release in allergic patients after the administration of midazolam-ketamine. A randomized controlled study

      INFLAMMATION RESEARCH
    19. Anibarro, PC; Carmona, JB; Gonzalez, FG; Sotillos, MG; Gil, DH; Gimenez, RP; Picon, SJ
      Allergic dermatitis due to oral ebrotidine

      JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY
    20. Kato, K; Jingu, S; Ogawa, N; Higuchi, S
      Rapid characterization of urinary metabolites of pibutidine hydrochloride in humans by liquid chromatography/electrospray ionization tandem mass spectrometry

      RAPID COMMUNICATIONS IN MASS SPECTROMETRY
    21. Bastaki, SMA; Wallace, JL
      Pathogenesis of nonsteroidal anti-inflammatory drug gastropathy: Clues to preventative therapy

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    22. Coruzzi, G; Pozzoli, C; Poli, E; Coppelli, G; Bertaccini, G
      Effects of histamine H-2 receptor agonists and antagonists on the isolatedguinea pig gallbladder

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    23. Atanassova, R; Petkov, O; Ivanov, C; Valchanova, N; Bozhikov, M
      Effects of 4-(4-bromophenyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride on acute gastric lesions, acid secretion in rats and on some hemodynamic parameters in cats

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    24. Andrade, RJ; Lucena, MI; Martin-Vivaldi, R; Fernandez, MC; Nogueras, F; Pelaez, G; Gomez-Outes, A; Garcia-Escano, MD; Bellot, V; Hervas, A; Cardenas, F; Bermudez, F; Romero, M; Salmeron, J
      Acute liver injury associated with the use of ebrotidine, a new H-2-receptor antagonist

      JOURNAL OF HEPATOLOGY
    25. Thomson, ABR; Kirdeikis, P; Lastiwka, R; Zuk, L; Jen, M; Elias, M; Johnston, P
      Food but not a chemically defined diet interferes with maintenance of intragastric pH at a predefined level using continuous pH-stat-adjusted intravenous infusion of ranitidine in healthy volunteers

      DIGESTIVE DISEASES AND SCIENCES
    26. Takeuchi, K; Kajimura, M; Kodaira, M; Lin, S; Hanai, H; Kaneko, E
      Up-regulation of H-2 receptor and adenylate cyclase in rabbit parietal cells during prolonged treatment with H-2-receptor antagonists

      DIGESTIVE DISEASES AND SCIENCES
    27. Zarling, EJ
      Prokinetic activity of nizatidine: Implications for the management of patients with gastroesophageal reflux disease

      CLINICAL THERAPEUTICS
    28. Tashiro, T; Ono, K; Watanabe, T; Inoie, M; Arai, H; Kimura, S; Kurokawa, K
      Histamine H-2 receptor antagonism by T-593: Studies on cAMP generation in Hepa cells expressing histamine H-2 receptor

      PHARMACOLOGY
    29. Onodera, S; Tanaka, M; Aoyama, M; Arai, Y; Inaba, N; Suzuki, T; Nishizawa, A; Shibata, M; Sekine, Y
      Antiulcer effect of lafutidine on indomethacin-induced gastric antral ulcers in refed rats

      JAPANESE JOURNAL OF PHARMACOLOGY
    30. Ishikawa, H; Ito, H; Higaki, M; Higaki, M; Matsumoto, Y; Kamimura, T; Katsura, Y; Tomishi, T; Inoue, Y; Takasugi, H; Tomoi, M; Krakowka, S; Yoshida, K
      FR145715, a novel histamine H-2 receptor antagonist, with specific anti-Helicobacter pylori activities

      EUROPEAN JOURNAL OF PHARMACOLOGY
    31. KIUCHI Y; ISOBE Y; KIJIMA H; HIGUCHI S; FUKUSHIMA K
      EFFECT OF PIBUTIDINE HYDROCHLORIDE ON NITRIC-OXIDE PRODUCTION IN RAT GASTRIC-MUCOSA

      Research communications in molecular pathology and pharmacology
    32. HIRAYAMA K; HANATSUKA K; IKEUCHI T; SHIDA D; OHTSUKA K; YOSHIMI F; HORI M; ITABASHI M; KOYAMA A
      FAMOTIDINE-INDUCED ACUTE INTERSTITIAL NEPHRITIS

      Nephrology, dialysis, transplantation
    33. STOABIRKETVEDT G; PAUS PN; GANSS R; INGEBRETSEN OC; FLORHOLMEN J
      CIMETIDINE REDUCES WEIGHT AND IMPROVES METABOLIC CONTROL IN OVERWEIGHT PATIENTS WITH TYPE-2 DIABETES

      International journal of obesity
    34. KIUCHI Y; ISOBE Y; KIJIMA H; SAITOH T; HIGUCHI S
      ROLE OF NITRIC-OXIDE AND PROSTAGLANDIN IN THE PROTECTIVE EFFECT OF PIBUTIDINE HYDROCHLORIDE, A NOVEL HISTAMINE H-2-RECEPTOR ANTAGONIST, ON THE GASTRIC-MUCOSAL LESIONS IN RATS

      General pharmacology
    35. PALACIOS B; MONTERO MJ; SEVILLA MA; SANROMAN L
      PHARMACOLOGY OF JB-9315, A NEW SELECTIVE HISTAMINE H-2-RECEPTOR ANTAGONIST

      General pharmacology
    36. YASUTAKE K; AMANO M; MIZOKAMI Y; KUBOTA S; FUKUMOTO H; IMAMURA Y; YOKOYA H; IRIE K
      EFFECTS OF CHANGING THE TYPE OF H-2-BLOCKER IN THE TREATMENT OF H-2-BLOCKER-RESISTANT ULCERS - COMPARISON OF ROXATIDINE ACETATE HYDROCHLORIDE AND OTHER H-2-BLOCKERS

      Journal of international medical research
    37. BASARAN UN; CELAYIR S; ERAY N; OZTURK R; SENYUZ OF
      THE EFFECT OF AN H-2-RECEPTOR ANTAGONIST ON SMALL-BOWEL COLONIZATION AND BACTERIAL TRANSLOCATION IN NEWBORN RATS

      Pediatric surgery international
    38. ADACHI Y; SHIOTA E; MATSUMATA T; ISO Y; YOH R; KITANO S
      BONE-MINERAL DENSITY IN PATIENTS TAKING H-2-RECEPTOR ANTAGONIST

      Calcified tissue international
    39. KUSANO M; SEKIGUCHI T; KAWAMURA O; KIKUCHI K; NAKAMURA K; MORI M
      DISTURBED INITIATION OF GASTRIC INTERDIGESTIVE MIGRATING COMPLEXES DESPITE HIGH PLASMA MOTILIN LEVELS IN PATIENTS WITH LOW GASTRIC PH

      Digestive diseases and sciences
    40. HAGA Y; NAKATSURA T; SHIBATA Y; SAMESHIMA H; NAKAMURA Y; TANIMURA M; OGAWA M
      HUMAN GASTRIC CARCINOID DETECTED DURING LONG-TERM ANTIULCER THERAPY OF H-2-RECEPTOR ANTAGONIST AND PROTON PUMP INHIBITOR

      Digestive diseases and sciences
    41. SHIBATA H; KUSAYANAGI Y; ARAI H; HASHIBA K; YAMAMOTO Y; ONODA M
      SYNTHESIS AND ANTIULCER ACTIVITY OF ROXY-2-PHENYL)ETHYL-N''-(METHANESULFONYL)GUANIDINE ANALOG OF RANITIDINE - DEVELOPMENT OF A NEW ANTIULCER AGENT T-593

      Yakugaku zasshi
    42. TAKAHASHI S; OKABE S
      ROLES OF EXTRACELLULAR CA-STIMULATED SECRETION AND SYNTHESIS OF MUCUSBY CULTURED RABBIT GASTRIC-MUCOSAL CELLS(+ AND CALMODULIN IN ROXATIDINE)

      The Journal of pharmacology and experimental therapeutics
    43. PRIMROSE JN; MILLER GV; PRESTON SR; GOKHALE J; AMBROSE NS; WARD UM; MILLS JG; EHSANULLAH RSB; DAREKAR B
      A PROSPECTIVE RANDOMIZED CONTROLLED-STUDY OF THE USE OF RANITIDINE INPATIENTS WITH GASTRIC-CANCER

      Gut
    44. SEKINE Y; HIRAKAWA N; KASHIWABA N; MATSUMOTO H; KUTSUMA T; YAMAURA T; SEKINE A
      A NOVEL HISTAMINE 2(H-2) RECEPTOR ANTAGONIST WITH GASTROPROTECTIVE ACTIVITY - I - SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF N-PHENOXYPROPYLACETAMIDE DERIVATIVES WITH THIOETHER FUNCTION

      Chemical and Pharmaceutical Bulletin
    45. HIRAKAWA N; MATSUMOTO H; HOSODA A; SEKINE A; YAMAURA T; SEKINE Y
      A NOVEL HISTAMINE 2(H-2) RECEPTOR ANTAGONIST WITH GASTROPROTECTIVE ACTIVITY - II - SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF 2-FURFURYL-THIO AND 2-FURFURYLSULFINYL ACETAMIDE DERIVATIVES WITH HETEROAROMATIC RINGS

      Chemical and Pharmaceutical Bulletin
    46. KIJIMA H; ISOBE Y; MURAMATSU M; YOKOMORI S; SUZUKI M; HIGUCHI S
      STRUCTURE-ACTIVITY CHARACTERIZATION OF AN H-2-RECEPTOR ANTAGONIST, YLOXY]-CIS-2-BUTENYLAMINO]-3-CYCLOBUTENE-1,2-DIONE HYDROCHLORIDE (IT-066), INVOLVED IN THE INSURMOUNTABLE ANTAGONISM AGAINST HISTAMINE-INDUCEDPOSITIVE CHRONOTROPIC ACTION IN GUINEA-PIG ATRIA

      Biochemical pharmacology
    47. ROZMAN E; GALCERAN MT; ALBET C
      DETERMINATION OF EBROTIDINE AND ITS METABOLITES IN HUMAN URINE BY REVERSED-PHASE ION-PAIR HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Journal of chromatography B. Biomedical sciences and applications
    48. KIUCHI Y; ISOBE Y; KIJIMA H; MURAMATSU M; HIGUCHI S
      EFFECT OF COLD-STRESS AND INDOMETHACIN ON THE BIOSYNTHESIS OF GASTRICSULFATED MUCIN IN RATS

      Research communications in molecular pathology and pharmacology
    49. MOAYYEDI P; CHALMERS DM; AXON ATR
      PATIENT FACTORS THAT PREDICT FAILURE OF OMEPRAZOLE, CLARITHROMYCIN, AND TINIDAZOLE TO ERADICATE HELICOBACTER-PYLORI

      Journal of gastroenterology
    50. KATAOKA H; ISOI T; KISO T; TANAKA C; SHINKAWA R; KAKITA T; SHOGAKI T; FURUKAWA M; OHTSUBO Y
      PHARMACOLOGICAL PROFILES OF A NEW ANTIULCER AGENT, SWR-215

      Biological & pharmaceutical bulletin
    51. JOHANSEN LV; LILDHOLDT T; BENDE M; TOFT A; PEDERSEN CB; DANIELSSON GP
      INFECTIOUS-MONONUCLEOSIS TREATED BY AN ANTIHISTAMINE - A COMPARISON OF THE EFFICACY OF RANITIDINE (ZANTAC(R)) VS PLACEBO IN THE TREATMENT OF INFECTIOUS-MONONUCLEOSIS

      Clinical otolaryngology and allied sciences
    52. GASBARRINI G; GENTILONI N; FEBBRARO S; GASBARRINI A; DICAMPLI C; CESANA M; MIGLIO F; MIGLIOLI M; GHINELLI F; DAMBROSI A; AMOROSO P; PACINI F; SALVADORI G
      ACUTE LIVER-INJURY RELATED TO THE USE OF NIPEROTIDINE

      Journal of hepatology
    53. WADIBIA EC; LUCAS D; HILLEMAN DE; MOOSS AN
      ECONOMIC-IMPACT OF INAPPROPRIATE HISTAMINE(2)-RECEPTOR ANTAGONIST USE

      Clinical therapeutics
    54. SATOH H; ASANO S; MAEDA R; MURAKAMI I; INADA I; SATO F; SHINO A
      PREVENTION OF GASTRIC-ULCER RELAPSE INDUCED BY INDOMETHACIN IN RATS BY A MUTEIN OF BASIC FIBROBLAST GROWTH-FACTOR

      Japanese Journal of Pharmacology
    55. KAWANISHI Y; ISHIHARA S; TAKAHASHI K; TSUSHIMA T; HAGISHITA S; ISHIKAWA M; ISHIHARA Y
      SYNTHESIS AND BIOLOGICAL EVALUATION OF A NEW REVERSELY LINKED TYPE OFDUAL HISTAMINE H-2 AND GASTRIN RECEPTOR ANTAGONIST

      Chemical and Pharmaceutical Bulletin
    56. ICHIKAWA T; ISHIHARA K; SAIGENJI K; HOTTA K
      STRUCTURAL REQUIREMENTS FOR ROXATIDINE IN THE STIMULANT EFFECT OF RATGASTRIC MUCIN SYNTHESIS AND THE PARTICIPATION OF NITRIC-OXIDE IN THISMECHANISM

      British Journal of Pharmacology
    57. ANGLADA L; RAGA M; MARQUEZ M; SACRISTAN A; CASTELLO JM; ORTIZ JA
      SYNTHESIS AND ASSESSMENT OF FORMAMIDINES AS NEW HISTAMINE H-2-RECEPTOR ANTAGONISTS

      Arzneimittel-Forschung
    58. ALBET C; FERNANDEZ JM; CASTELLO JM; SACRISTAN A; ORTIZ JA
      PHYSICOCHEMICAL PROPERTIES, ANALYTICAL DETERMINATIONS AND STABILITY OF EBROTIDINE

      Arzneimittel-Forschung
    59. PALOP D; AGUT J; MARQUEZ M; CONEJO L; SACRISTAN A; ORTIZ JA
      HISTAMINE H-2-RECEPTOR ANTAGONIST ACTION OF EBROTIDINE - EFFECTS ON GASTRIC-ACID SECRETION, GASTRIN-LEVELS AND NSAID-INDUCED GASTROTOXICITYIN THE RAT

      Arzneimittel-Forschung
    60. AGUT J; SANCHEZ JC; SACRISTAN A; ORTIZ JA
      ACTION OF EBROTIDINE, RANITIDINE AND CIMETIDINE ON THE SPECIFIC BINDING TO HISTAMINE H-1-RECEPTOR AND H-2-RECEPTOR

      Arzneimittel-Forschung
    61. PALOP D; ROMERO A; VILLAMAYOR F; CONEJO L; SACRISTAN A; ORTIZ JA
      EFFECT OF EBROTIDINE ON ETHANOL-INDUCED GASTRIC-MUCOSAL DAMAGE IN THERAT - COMPARATIVE-STUDY WITH OTHER H-2-RECEPTOR ANTAGONISTS

      Arzneimittel-Forschung
    62. ROMERO A; VILLAMAYOR F; PALOP D; FALCO J; SACRISTAN A; ORTIZ JA
      STUDY ON THE INCREMENT OF THE AMOUNT OF GASTRIC MUCUS IN RATS AFTER REPEATED-DOSE ADMINISTRATION OF EBROTIDINE

      Arzneimittel-Forschung
    63. SLOMIANY BL; PIOTROWSKI J; SLOMIANY A
      GASTROPROTECTIVE PROPERTIES OF EBROTIDINE - A REVIEW

      Arzneimittel-Forschung
    64. PALOP D; CONEJO L; SACRISTAN A; ORTIZ JA
      INVOLVEMENT OF ENDOGENOUS NITRIC-OXIDE AND SULFHYDRYL COMPOUNDS IN EBROTIDINE-INDUCED GASTROPROTECTION

      Arzneimittel-Forschung
    65. PALACIN C; TARRAGO C; SACRISTAN A; ORTIZ JA
      IN-VITRO ANTI-HELICOBACTER PYLORI ACTIVITY OF EBROTIDINE

      Arzneimittel-Forschung
    66. SLOMIANY BL; PIOTROWSKI J; SLOMIANY A
      ANTI-HELICOBACTER PYLORI ACTIVITIES OF EBROTIDINE - A REVIEW OF BIOCHEMICAL AND ANIMAL EXPERIMENTAL STUDIES AND DATA

      Arzneimittel-Forschung
    67. ALBET C; PEREZ JA; SACRISTAN A; ORTIZ JA
      PHARMACOKINETICS OF EBROTIDINE IN RATS AND DOGS

      Arzneimittel-Forschung
    68. ROZMAN E; ALBET C; SACRISTAN A; ORTIZ JA
      METABOLISM OF EBROTIDINE - A REVIEW

      Arzneimittel-Forschung
    69. GRAU MT; ROMERO A; VILLAMAYOR F; SACRISTAN A; ORTIZ JA
      ACUTE TOXICITY STUDIES OF EBROTIDINE

      Arzneimittel-Forschung
    70. ROMERO A; GRAU MT; VILLAMAYOR F; SACRISTAN A; ORTIZ JA
      SUBACUTE TOXICITY OF EBROTIDINE IN RATS AND DOGS

      Arzneimittel-Forschung
    71. ROMERO A; GRAU MT; VILLAMAYOR F; SACRISTAN A; ORTIZ JA
      CHRONIC TOXICITY OF EBROTIDINE IN RATS AND DOGS

      Arzneimittel-Forschung
    72. ROMERO A; GRAU MT; VILLAMAYOR F; SACRISTAN A; ORTIZ JA
      TOXICITY OF EBROTIDINE ON REPRODUCTION - TOXICITY ON FERTILITY AND GENERAL REPRODUCTIVE-PERFORMANCE, EMBRYO-FETAL TOXICITY AND PERI-NATAL AND POSTNATAL TOXICITY

      Arzneimittel-Forschung
    73. ROMERO A; PALACIN C; CILIUTTI P; VERICAT JA; MARCOS R; MONTERO R; GARCIA M; VILLAMAYOR F
      GENOTOXICITY STUDIES ON EBROTIDINE

      Arzneimittel-Forschung
    74. ROMERO A; RIVES A; GRAU MT; VILLAMAYOR F; SACRISTAN A; ORTIZ JA
      CARCINOGENICITY STUDIES AN EBROTIDINE

      Arzneimittel-Forschung
    75. ROMERO A; GOMEZ F; VILLAMAYOR F; SACRISTAN A; ORTIZ JA
      STUDY OF THE POPULATION OF ANTRAL G-CELLS AND ENTEROCHROMAFFIN-LIKE CELLS IN THE RAT AND MOUSE GASTRIC-MUCOSA AFTER LONG-TERM TREATMENT WITH EBROTIDINE

      Arzneimittel-Forschung
    76. ROMERO A; GOMEZ F; VILLAMAYOR F; BALLESTA A; SACRISTAN A; ORTIZ JA
      COMPARATIVE-STUDY OF PLASMA GASTRIN-LEVELS IN RATS AFTER 2 MONTHS OF EBROTIDINE ADMINISTRATION

      Arzneimittel-Forschung
    77. FARRE M; ROSET PN; BADENAS JM; UGENA B; MARQUEZ M; ALBET C; HERRERO E; ORTIZ JA
      TOLERABILITY AND PHARMACOKINETICS OF EBROTIDINE IN HEALTHY-SUBJECTS GIVEN SINGLE AND REPEATED ORAL DOSES

      Arzneimittel-Forschung
    78. FRIAS J; ESTEBAN C; CARCAS AJ; SANCHEZGARCIA P; ALBET C; TORRES J; MARQUEZ M; ORTIZ JA
      PHARMACOKINETIC STUDY OF EBROTIDINE ADMINISTERED IN MULTIPLE DOSES TOHEALTHY-VOLUNTEERS FOR 4 DAYS

      Arzneimittel-Forschung
    79. ALBET C; PEREZ JA; ROZMAN E; MARQUEZ M; HERRERO E; ORTIZ JA
      PHARMACOKINETICS OF EBROTIDINE IN HEALTHY-VOLUNTEERS - A SUMMARY

      Arzneimittel-Forschung
    80. MUNOZNAVAS M; HONORATO J; REINAARINO M; MARQUEZ M; HERRERO E; VILLAMAYOR F; TORRES J; ROSET PN; FILLAT O; CAMPS F; ORTIZ JA
      CONTINUOUS INTRAGASTRIC PH MONITORING IN THE EVALUATION OF EBROTIDINE, CIMETIDINE AND PLACEBO ON GASTRIC-ACIDITY IN HEALTHY-VOLUNTEERS

      Arzneimittel-Forschung
    81. GABRYELEWICZ A; CZAJKOWSKI A; SKRODZKA D; MARLICZ K; DETENA FL; ALDEGUER M; CHANTAR C; MARQUEZ M; TORRES J; ORTIZ JA
      COMPARISON OF THE EFFICACY AND SAFETY OF EBROTIDINE IN THE TREATMENT OF DUODENAL-ULCER - A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE-II STUDY

      Arzneimittel-Forschung
    82. TULASSAY Z; DOBRONTE Z; FARKAS I; JUHASZ L; SIMON L; PRONAI L; TORRES J; MARQUEZ M
      EBROTIDINE VERSUS RANITIDINE IN THE HEALING AND PREVENTION OF RELAPSEOF DUODENAL-ULCER - A MULTICENTER, DOUBLE-BLIND, PARALLEL, RANDOMIZED, CONTROLLED-STUDY

      Arzneimittel-Forschung
    83. MATOV V; METCHKOV G; KRASTEV Z; TCHERNEV K; MITOVA R; MARQUEZ M; TORRES J; HERRERO E; FILLAT O; ORTIZ JA
      EBROTIDINE VERSUS RANITIDINE IN THE TREATMENT OF ACUTE DUODENAL-ULCER- A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED CLINICAL-TRIAL

      Arzneimittel-Forschung
    84. GEDLICZKA O; BOBRZYNSKI A; REMBIASZ K; FILLAT O; TORRES J; HERRERO E; MARQUEZ M; CAMPS F; ORTIZ JA
      EFFICACY OF EBROTIDINE AND RANITIDINE IN THE TREATMENT OF BENIGN GASTRIC-ULCER

      Arzneimittel-Forschung
    85. PUSCAS I; PUSCAS C; COLTAU M; TORRES J; MARQUEZ M; HERRERO E; FILLAT O; ORTIZ JA
      STUDIES ON THE PROTECTIVE EFFECT OF EBROTIDINE ON EXPERIMENTAL ULCERSINDUCED BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN HEALTHY-VOLUNTEERS

      Arzneimittel-Forschung
    86. PUSCAS I; PUSCAS C; COLTAU M; PASCA R; TORRES J; MARQUEZ M; HERRERO E; FILLAT O; ORTIZ JA
      COMPARATIVE-STUDY OF THE SAFETY AND EFFICACY OF EBROTIDINE VERSUS RANITIDINE AND PLACEBO IN THE PREVENTION OF PIROXICAM-INDUCED GASTRODUODENAL LESIONS

      Arzneimittel-Forschung
    87. POPIELA T; KULIG J; KARCZ D; TABOR J; TORRES J; MARQUEZ M; FILLAT O; HERRERO E; ORTIZ JA
      EFFICACY OF EBROTIDINE AND RANITIDINE COMBINED WITH AMOXICILLIN AND METRONIDAZOLE IN THE ERADICATION OF HELICOBACTER-PYLORI IN PATIENTS WITH DUODENAL-ULCER

      Arzneimittel-Forschung
    88. KONTUREK PC; BRZOZOWSKI T; KONTUREK SJ; MARQUEZ M; TORRES J; ORTIZ JA
      STUDIES ON THE CYTOPROTECTIVE AND ANTISECRETORY ACTIVITY OF EBROTIDINE - A REVIEW

      Arzneimittel-Forschung
    89. STOABIRKETVEDT G; WALDUM HL; VONEN B; FLORHOLMEN J
      EFFECT OF CIMETIDINE ON BASAL AND POSTPRANDIAL PLASMA-CONCENTRATIONS OF CHOLECYSTOKININ AND GASTRIN IN HUMANS

      Acta Physiologica Scandinavica
    90. LAMERS CBHW
      THE CHANGING-ROLE OF H-2-RECEPTOR ANTAGONISTS IN ACID-RELATED DISEASES

      European journal of gastroenterology & hepatology
    91. SIMONS KJ; CHEN X; FRASER TG; SIMONS FER
      EFFECT OF CIMETIDINE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF CHLORPHENIRAMINE AND DIPHENHYDRAMINE IN RABBITS

      Pharmaceutical research
    92. TANIOKA H; KAGA K
      COMPARISON OF ROXATIDINE AND FAMOTIDINE ON NOCTURNAL GASTRIC-JUICE SECRETION

      Journal of international medical research
    93. REILLY TG; SINGH S; COTTRELL J; MANN SG; STAUFFER L; WALT RP
      LOW-DOSE FAMOTIDINE AND RANITIDINE AS SINGLE POSTPRANDIAL DOSES - A 3-PERIOD PLACEBO-CONTROLLED COMPARATIVE TRIAL

      Alimentary pharmacology & therapeutics
    94. ROMERO A; GOMEZ F; VILLAMAYOR F; SACRISTAN A; ORTIZ JA
      STUDY OF THE POPULATION OF ENTEROCHROMAFFIN-LIKE CELLS IN MOUSE GASTRIC-MUCOSA AFTER LONG-TERM TREATMENT WITH EBROTIDINE

      Toxicologic pathology
    95. FUSAMOTO H; KAWANO S; TSUJI S; OSHITA M; NAGANO K; OHMAE A; SAWAOKA H; NAGAI Y; KASAHARA A; SUGIMOTO T; KAMADA T
      ENDOSCOPIC APPEARANCES OF HEMORRHAGIC PEPTIC-ULCERS AND EFFICACY OF H-2-RECEPTOR ANTAGONISTS

      Hepato-gastroenterology
    96. MAGEE LA; INOCENCION G; KAMBOJ L; ROSETTI F; KOREN G
      SAFETY OF FIRST TRIMESTER EXPOSURE TO HISTAMINE H-2 BLOCKERS - A PROSPECTIVE COHORT STUDY

      Digestive diseases and sciences
    97. KAWASHIMA O; YAMAUCHI M; MAEZAWA Y; TODA G
      EFFECTS OF CIMETIDINE ON BLOOD ETHANOL LEVELS AFTER ALCOHOL INGESTIONAND GENETIC POLYMORPHISMS OF SIGMA-ALCOHOL DEHYDROGENASE IN JAPANESE

      Alcoholism, clinical and experimental research
    98. GONZALOGARIJO MA; REVENGAARRANZ F; ROVIRAFARRE I
      CUTANEOUS DELAYED-REACTION TO RANITIDINE

      Allergy
    99. LAMBERTI C; BARTOLINI A; GHELARDINI C; MALMBERGAIELLO P
      INVESTIGATION INTO THE ROLE OF HISTAMINE-RECEPTORS IN RODENT ANTINOCICEPTION

      Pharmacology, biochemistry and behavior
    100. KIM KY; MCCARTNEY JR; KAYE W; BOLAND RJ; NIAURA R
      THE EFFECT OF CIMETIDINE AND RANITIDINE ON COGNITIVE FUNCTION IN POSTOPERATIVE CARDIAC SURGICAL PATIENTS

      International journal of psychiatry in medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 17/02/20 alle ore 08:30:36